Janel Olson
Nurse Practitioner · Bismarck, NDNPI 1841501236
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 240 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by Novartis at 24.7% of the total. Among nurse practitioner clinicians in ND with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 240 payments — averaging $15.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$891
- Pfizer$681
- Amgen$346
- E.r. Squibb & Sons, L.L.C.$281
- Boehringer Ingelheim$242
- Novo Nordisk$202
- plus $965 from 16 others
What the payments were for
- Food & beverage$3,607100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 74 | $891 |
| Pfizer | 44 | $681 |
| Amgen | 17 | $346 |
| E.r. Squibb & Sons, L.L.C. | 21 | $281 |
| Boehringer Ingelheim | 13 | $242 |
| Novo Nordisk | 15 | $202 |
| Merck | 9 | $145 |
| Lexicon Pharmaceuticals, Inc. | 8 | $136 |
| Johnson & Johnson | 8 | $123 |
| Kiniksa Pharmaceuticals International, PLC | 5 | $96 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 6 | $81 |
| Alnylam Pharmaceuticals Inc. | 4 | $62 |
| United Therapeutics Corporation | 3 | $53 |
| Daiichi Sankyo Inc. | 3 | $48 |
| AstraZeneca | 3 | $45 |
| Itamar Medical Inc | 1 | $41 |
| Lemaitre Vascular, Inc. | 1 | $33 |
| Bridgebio Pharma, Inc. | 1 | $26 |
| Abbott | 1 | $22 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $21 |
| Actelion Pharmaceuticals US, Inc. | 1 | $18 |
| Boston Scientific | 1 | $16 |
How this compares
$3,607 in reported general payments places this provider in the 95th percentile of 455 nurse practitioner providers in North Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 741 | $637,275 |
| XareltoRivaroxaban | 209 | $192,183 |
| Repatha SureclickEvolocumab | 109 | $72,289 |
| Praluent PenAlirocumab | 71 | $50,362 |
| JardianceEmpagliflozin | 58 | $46,641 |
| Metoprolol Succinate | 1,379 | $28,442 |
| Repatha SyringeEvolocumab | 37 | $26,173 |
| EntrestoSacubitril/Valsartan | 35 | $25,455 |
| LivaloPitavastatin Calcium | 36 | $18,600 |
| Rosuvastatin Calcium | 1,087 | $16,421 |
| Atorvastatin Calcium | 837 | $9,454 |
| Losartan Potassium | 631 | $8,323 |
| Ezetimibe | 345 | $7,497 |
| Potassium Chloride | 230 | $7,042 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 366 | $6,822 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $681 | $637,275741 claims |
| Johnson & JohnsonXarelto | $123 | $192,183209 claims |
| Boehringer IngelheimJardiance | $242 | $46,64158 claims |
| NovartisEntresto | $891 | $25,45535 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 455 nurse practitioner providers in North Dakota.
Other nurse practitioner in Bismarck
- Lisa ClairmontBismarck$15K
- McKinzie NussBismarck$7K
- Paula MochBismarck$5K
- Trina KaiserBismarck$5K
- Cassie HoltBismarck$5K
- Katherine CarvellBismarck$5K
- Shih Ru MartinBismarck$5K
- Mallorie EmoryBismarck$3K
- Kayla CoferBismarck$3K
- Camille MeyhoffBismarck$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.